Effect of 14 days of treatment (T14) on immunological parameters
| Fluticasone (n=11) | Placebo (n=12) | p value 5-151 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Median | Range | Median | Range | ||||||
| T cells | 0.69 | 0.41–1.59 | 1.03 | 0.68–1.36 | 0.015 | ||||
| Primed T cells | 0.68 | 0.35–1.7 | 1.02 | 0.57–1.3 | 0.021 | ||||
| CD4:CD8 ratios | 0.95 | 0.22–2.5 | 0.81 | 0.25–1.69 | 0.97 | ||||
| CD68+ cells | 0.72 | 0.45–1.39 | 1.03 | 0.32–1.15 | 0.023 | ||||
| D1+MQ | 0.69 | 0.25–4.6 | 0.8 | 0.53–1.4 | 0.16 | ||||
| D7+MQ | 1.27 | 0.74–2.15 | 1.25 | 0.78–1.79 | 0.91 | ||||
| D1+/D7+MQ | 0.88 | 0.45–2.45 | 0.88 | 0.45–1.86 | 0.77 | ||||
| Eosinophils | 0.67 | 0.03–1.16 | 0.98 | 0.02–38 | 0.045 | ||||
| Activated eosinophils | 0.67 | 0.03–1.78 | 1.0 | 0.13–16 | 0.12 | ||||
5-150 All figures are ratios reflecting T14/T0 data for each parameter.
↵5-151 Mann-Whitney test for non-parametric data.